| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Kuei Y Tseng | |
| Anthony R West | |||
| P2860 | cites work | Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide? | Q72147873 |
| Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens | Q73101598 | ||
| [The nitric oxide system in a chronic deficiency of mesostriatal dopamine: the action of nitroglycerin] | Q73926279 | ||
| Nitrergic neurons make synapses on dual-input dendritic spines of neurons in the cerebral cortex and the striatum of the rat: implication for a postsynaptic action of nitric oxide | Q74272633 | ||
| Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry | Q24630976 | ||
| Nitric oxide synthases: structure, function and inhibition | Q28207668 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice | Q28370408 | ||
| Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation | Q28387521 | ||
| Endogenous nitric oxide modulates behavioural effects elicited by substance P in rat | Q71686341 | ||
| NADPH-diaphorase/nitric oxide synthase containing neurons in normal and Parkinson's disease putamen | Q71687246 | ||
| Stimulation of immediate early gene expression in striatal neurons by nitric oxide | Q71743337 | ||
| Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation | Q28582177 | ||
| D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
| The functional anatomy of basal ganglia disorders | Q29617461 | ||
| Functional architecture of basal ganglia circuits: neural substrates of parallel processing | Q29618729 | ||
| Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
| Ultrastructural features of the nitric oxide synthase-containing interneurons in the nucleus accumbens and their relationship with tyrosine hydroxylase-containing terminals | Q31912070 | ||
| Evidence of a breakdown of corticostriatal connections in Parkinson's disease. | Q33214147 | ||
| Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo | Q33618380 | ||
| Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades | Q33762162 | ||
| Synaptic transmission in the striatum: from plasticity to neurodegeneration | Q33869405 | ||
| Metabolic effects of nigrostriatal denervation in basal ganglia. | Q34070899 | ||
| The neurobiology of slow synaptic transmission | Q34100272 | ||
| Extrinsic connections of the basal ganglia | Q34570614 | ||
| Circuits and circuit disorders of the basal ganglia | Q34599488 | ||
| Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms | Q34621009 | ||
| Brain oscillations, medium spiny neurons, and dopamine. | Q35065827 | ||
| Nitric oxide signaling in brain: potentiating the gain with YC-1. | Q35133276 | ||
| Novel neural modulators | Q35550535 | ||
| GABAergic microcircuits in the neostriatum | Q35912996 | ||
| Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine. | Q35968238 | ||
| Role of nitric oxide on motor behavior | Q36209135 | ||
| In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation | Q36247620 | ||
| Where do you think you are going? The NMDA-D1 receptor trap | Q36466901 | ||
| Dopamine-mediated regulation of corticostriatal synaptic plasticity. | Q36762821 | ||
| Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease | Q36899588 | ||
| Concepts of neural nitric oxide-mediated transmission | Q37029494 | ||
| Neuronal NADPH diaphorase is a nitric oxide synthase | Q37463023 | ||
| Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues | Q37588180 | ||
| Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection | Q37629163 | ||
| Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions | Q37800377 | ||
| Guanylate cyclase activity in various rat brain areas | Q39156108 | ||
| Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. | Q39801798 | ||
| Nitric oxide: a radical neurotransmitter in the central nervous system | Q40371016 | ||
| Brain monoamines and parkinsonism | Q40604961 | ||
| Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity | Q42028032 | ||
| Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. | Q42461972 | ||
| Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. | Q42468515 | ||
| Dopamine modulates release from corticostriatal terminals. | Q42469821 | ||
| Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo | Q42486333 | ||
| Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. | Q42493069 | ||
| Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease | Q42497576 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. | Q42508172 | ||
| Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions | Q42949389 | ||
| Developmental alterations of DHPG-induced long-term depression of corticostriatal synaptic transmission: switch from NMDA receptor-dependent towards CB1 receptor-dependent plasticity | Q43287350 | ||
| Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat. | Q43846210 | ||
| Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus | Q43856112 | ||
| Cortico-striatal synaptic plasticity in endothelial nitric oxide synthase deficient mice | Q44306274 | ||
| Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats. | Q44751890 | ||
| The nitric oxide-guanylyl cyclase signaling pathway modulates membrane activity States and electrophysiological properties of striatal medium spiny neurons recorded in vivo. | Q44777528 | ||
| Distribution of soluble guanylyl cyclase in the rat brain | Q44830862 | ||
| Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease. | Q44842409 | ||
| Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice | Q45090228 | ||
| Influence of the therapy with pergolide mesylate plus L-DOPA and with L-DOPA alone on serum cGMP level in PD patients. | Q45183174 | ||
| Coadministration of L-NOARG and tiapride: effects on catalepsy in male mice. | Q45711983 | ||
| Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease | Q46080337 | ||
| Localization of nitric oxide synthase indicating a neural role for nitric oxide | Q46202294 | ||
| Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists | Q46414114 | ||
| Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. | Q46418668 | ||
| Feedforward inhibition of projection neurons by fast-spiking GABA interneurons in the rat striatum in vivo. | Q46437163 | ||
| Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism | Q46597028 | ||
| Feed-forward excitation of striatal neuron activity by frontal cortical activation of nitric oxide signaling in vivo | Q46678905 | ||
| In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway | Q46686653 | ||
| Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum | Q46717751 | ||
| Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 | ||
| Frontal cortical afferents facilitate striatal nitric oxide transmission in vivo via a NMDA receptor and neuronal NOS-dependent mechanism | Q48089471 | ||
| Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice | Q48125636 | ||
| Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine | Q48154745 | ||
| Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex | Q48204220 | ||
| The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. | Q48231742 | ||
| A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. | Q48257417 | ||
| Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat. | Q48299593 | ||
| Dopamine D2 receptor-dependent modulation of striatal NO synthase activity | Q48317923 | ||
| Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution | Q48440660 | ||
| Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. | Q48499640 | ||
| Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release | Q48502195 | ||
| The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture | Q48543386 | ||
| Ultrastructural study of nitric oxide synthase-containing striatal neurons and their relationship with parvalbumin-containing neurons in rats | Q48558162 | ||
| Distribution of components of the guanosine 3',5'-phosphate system in rat caudate-putamen | Q48722677 | ||
| Cortical afferents modulate striatal gap junction permeability via nitric oxide | Q48825555 | ||
| Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP. | Q48967375 | ||
| 7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. | Q50538146 | ||
| Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum | Q51652804 | ||
| Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels. | Q52079554 | ||
| NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis | Q57727152 | ||
| Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age | Q69262673 | ||
| Association of dopaminergic terminals and neurons releasing nitric oxide in the rat striatum: an electron microscopic study using NADPH-diaphorase histochemistry and tyrosine hydroxylase immunohistochemistry | Q71304522 | ||
| The correlation between neuron counts and optical density of NADPH-diaphorase histochemistry in the rat striatum: a quantitative study | Q71669551 | ||
| P921 | main subject | striatum | Q1319792 |
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | 55 | |
| P577 | publication date | 2011-06-30 | |
| P1433 | published in | Frontiers in Systems Neuroscience | Q15816495 |
| P1476 | title | Nitric Oxide-Soluble Guanylyl Cyclase-Cyclic GMP Signaling in the Striatum: New Targets for the Treatment of Parkinson's Disease? | |
| P478 | volume | 5 |
| Q28390090 | Age-related alterations in the expression of genes and synaptic plasticity associated with nitric oxide signaling in the mouse dorsal striatum |
| Q28392899 | Cross-regulation of Phosphodiesterase 1 and Phosphodiesterase 2 Activities Controls Dopamine-mediated Striatal α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking |
| Q38234309 | Direct and indirect pathways of basal ganglia: a critical reappraisal |
| Q40706995 | Dopamine in the pathogenesis of minimal hepatic encephalopathy: a new player? |
| Q35307838 | Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways. |
| Q52147479 | Frequency-Dependent Corticostriatal Disinhibition Resulting from Chronic Dopamine Depletion: Role of Local Striatal cGMP and GABA-AR Signaling. |
| Q92674252 | Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease |
| Q34440714 | Investigations into Potential Extrasynaptic Communication between the Dopaminergic and Nitrergic Systems. |
| Q43163005 | Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. |
| Q40785212 | Mutual Control of Cholinergic and Low-Threshold Spike Interneurons in the Striatum |
| Q38038559 | New synaptic and molecular targets for neuroprotection in Parkinson's disease |
| Q90049652 | Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide |
| Q26753116 | Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications |
| Q47909580 | Regulation of Striatal Neuron Activity by Cyclic Nucleotide Signaling and Phosphodiesterase Inhibition: Implications for the Treatment of Parkinson's Disease. |
| Q28394979 | Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition |
| Q26852381 | Role of nitric oxide in the regulation of motor function. An overview of behavioral, biochemical and histological studies in animal models |
| Q24614161 | Serotonin inhibits low-threshold spike interneurons in the striatum |
| Q37317832 | The NO/cGMP pathway inhibits transient cAMP signals through the activation of PDE2 in striatal neurons. |
| Q28481326 | The nitric oxide-cyclic GMP pathway regulates FoxO and alters dopaminergic neuron survival in Drosophila |
| Q38196367 | The role of glutamate and its receptors in multiple sclerosis |
| Q54225221 | [Physiopathology of cAMP/PKA signaling in neurons]. |
Search more.